Candel Therapeutics Secures FDA RMAT Designation for CAN-2409 in Localized Prostate Cancer

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological ...

May 29, 2025 | Thursday | News
Celltrion Secures Full Interchangeability Designation for YUFLYMA® Across All Adalimumab Dosage Forms in the U.S.

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimil...

May 27, 2025 | Tuesday | News
Roche and Broad Clinical Labs Partner to Advance Genomics with SBX Sequencing, Starting with Critically Ill Newborns

The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche’s SBX sequencing technology1, with an init...

May 26, 2025 | Monday | News
QIAGEN and ID Solutions Partner to Expand Oncology dPCR Assay Portfolio on QIAcuity Platform

Partnership designed to expand QIAGEN’s leadership in oncology-focused digital PCR assays, advancing QIAcuity as the platform of choice for can...

May 23, 2025 | Friday | News
Rani Therapeutics and Chugai Pharmaceutical Collaborate to Evaluate Oral Biologics Delivery via RaniPill®

Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs,  announced the compa...

May 21, 2025 | Wednesday | News
CRISPR Therapeutics and Sirius Therapeutics Partner to Advance Long-Acting siRNA Therapy for Thromboembolic Disorders

Collaboration brings together complementary capabilities to co-develop and co-commercialize SRSD107, a next generation, long-acting Factor XI (FXI) small...

May 20, 2025 | Tuesday | News
Brain Cancer Canada Awards $68,000 to Advance Neoantigen-Based Vaccine Research for Deadly Childhood Brain Tumors

Brain Cancer Canada is pleased to award $68,000 for an innovative research initiative led by Dr. Aru Narendran, MD, PhD, and Dr. Patrick Sipila, PhD, at ...

May 19, 2025 | Monday | News
Silo Pharma Engages Veloxity Labs to Advance IND-Enabling Study for PTSD Treatment Candidate SPC-15

Silo Pharma, Inc., a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems,  announced that it has e...

May 15, 2025 | Thursday | News
Azenta’s GENEWIZ and Form Bio Partner to Accelerate AAV Gene Therapy Development with Integrated Sequencing and AI Analysis

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. Azenta, Inc.a...

May 14, 2025 | Wednesday | News
BD Launches FACSDiscover™ A8 Cell Analyzer to Redefine Flow Cytometry with Spectral and Real-Time Imaging Technologies

BD a leading global medical technology company, announced the global commercial launch of the world's first cell analyzer featuring breakthrough spectral...

May 14, 2025 | Wednesday | News
MaxisIT Evolves into Maxis AI, Launches Agentic AI Platform to Transform Clinical Trials

MaxisIT, a long-recognized provider of clinical data analytics platform for clinical trials, today announced its transformation into Maxis AI. This strat...

May 13, 2025 | Tuesday | News
Etcembly Partners with DJS Antibodies, Part of AbbVie, to Accelerate AI-Driven Antibody Discovery

British techbio innovator Etcembly has signed a collaboration agreement with DJS Antibodies, a part of AbbVie, to accelerate the discovery of novel antib...

May 13, 2025 | Tuesday | News
Shuttle Pharma Nears 50% Enrollment in Phase 2 Trial of Ropidoxuridine for Glioblastoma with Promising Tolerability and Completion Rates

Shuttle Pharmaceuticals Holdings, Inc. , a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer pati...

May 09, 2025 | Friday | News
GeneFab and RegCell Unite to Accelerate U.S. Clinical Manufacturing of Next-Gen Treg Therapies

GeneFab, a next-generation cell and gene therapy-focused contract research, development, and manufacturing organization (CRDMO), has partnered with RegCe...

May 08, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close